Please login to the form below

Not currently logged in
Email:
Password:

Shire’s Dr Armin Reininger moves to Sobi

Appointed as senior vice president, head of global medical and scientific affairs

Sobi Dr Armin ReiningerStockholm-based Sobi has appointed Dr Armin Reininger as a senior vice president and head of global medical and scientific affairs.

Dr Reininger joins the rare diseases specialist from Shire, where he most recently served as head of medical affairs for haematology, EMEA at Baxalta, having first joined Baxter as head of global medical affairs for haemophilia.

Prior to this, Dr Reininger held several academic research and clinical positions at the Ludwig Maximillian University in Munich, Germany, The Scripps Research Institute, and Harvard Medical School.

Geoffrey McDonough, president and chief executive officer at Sobi, said: “We are truly delighted to welcome Armin to Sobi.

“Armin will apply his deep experience as an industry leader and academic in haemophilia to our team, as well as his global experience in medical scientific affairs to our stakeholders.”

17th January 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics